» Articles » PMID: 32699281

Label-free Detection of Rare Circulating Tumor Cells by Image Analysis and Machine Learning

Overview
Journal Sci Rep
Specialty Science
Date 2020 Jul 24
PMID 32699281
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Detection and characterization of rare circulating tumor cells (CTCs) in patients' blood is important for the diagnosis and monitoring of cancer. The traditional way of counting CTCs via fluorescent images requires a series of tedious experimental procedures and often impacts the viability of cells. Here we present a method for label-free detection of CTCs from patient blood samples, by taking advantage of data analysis of bright field microscopy images. The approach uses the convolutional neural network, a powerful image classification and machine learning algorithm to perform label-free classification of cells detected in microscopic images of patient blood samples containing white blood cells and CTCs. It requires minimal data pre-processing and has an easy experimental setup. Through our experiments, we show that our method can achieve high accuracy on the identification of rare CTCs without the need for advanced devices or expert users, thus providing a faster and simpler way for counting and identifying CTCs. With more data becoming available in the future, the machine learning model can be further improved and can serve as an accurate and easy-to-use tool for CTC analysis.

Citing Articles

MIML: multiplex image machine learning for high precision cell classification via mechanical traits within microfluidic systems.

Islam K, Paul R, Wang S, Zhao Y, Adhikary P, Li Q Microsyst Nanoeng. 2025; 11(1):43.

PMID: 40050640 PMC: 11885814. DOI: 10.1038/s41378-025-00874-x.


Deep learning-based lung cancer risk assessment using chest computed tomography images without pulmonary nodules ≥8 mm.

Yang S, Lim S, Hong J, Park J, Kim J, Kim H Transl Lung Cancer Res. 2025; 14(1):150-162.

PMID: 39958220 PMC: 11826273. DOI: 10.21037/tlcr-24-882.


A Hybrid Intelligence Approach for Circulating Tumor Cell Enumeration in Digital Pathology by Using CNN and Weak Annotations.

Tong L, Wan Y IEEE Access. 2024; 11:142992-143003.

PMID: 38957613 PMC: 11218908. DOI: 10.1109/access.2023.3343701.


Acoustofluidic Actuation of Living Cells.

Wu Y, Gai J, Zhao Y, Liu Y, Liu Y Micromachines (Basel). 2024; 15(4).

PMID: 38675277 PMC: 11052308. DOI: 10.3390/mi15040466.


The Role of Circulating Tumor Cells as a Liquid Biopsy for Cancer: Advances, Biology, Technical Challenges, and Clinical Relevance.

Allen T Cancers (Basel). 2024; 16(7).

PMID: 38611055 PMC: 11010957. DOI: 10.3390/cancers16071377.


References
1.
Rossi E, Fassan M, Aieta M, Zilio F, Celadin R, Borin M . Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancer. Br J Cancer. 2012; 107(8):1286-94. PMC: 3494437. DOI: 10.1038/bjc.2012.388. View

2.
OFlaherty J, Gray S, Richard D, Fennell D, OLeary J, Blackhall F . Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer. Lung Cancer. 2012; 76(1):19-25. DOI: 10.1016/j.lungcan.2011.10.018. View

3.
Chen C, Mahjoubfar A, Tai L, Blaby I, Huang A, Niazi K . Deep Learning in Label-free Cell Classification. Sci Rep. 2016; 6:21471. PMC: 4791545. DOI: 10.1038/srep21471. View

4.
Alix-Panabieres C, Pantel K . Challenges in circulating tumour cell research. Nat Rev Cancer. 2014; 14(9):623-31. DOI: 10.1038/nrc3820. View

5.
Danaee P, Ghaeini R, Hendrix D . A DEEP LEARNING APPROACH FOR CANCER DETECTION AND RELEVANT GENE IDENTIFICATION. Pac Symp Biocomput. 2016; 22:219-229. PMC: 5177447. DOI: 10.1142/9789813207813_0022. View